Browsing by Author "Casadevall Aguilar, David"

Sort by: Order: Results:

  • Rocha, Pedro P.; Ramal, Didac; Ripoll, Enric; Moliner, Laura; Corbera-Lloret, Alex; Hardy-Werbin, Max; Orrillo, Mayra; Taus García, Álvaro; Zuccarino, Flavio; Gibert Fernandez, Joan 1988-; Perera Bel, Júlia; Casadevall Aguilar, David; Arriola Aperribay, Edurne (Elsevier, 2020)
    Introduction: Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported in multiple studies. However, inconsistent results in incidence and survival outcomes within studies, ...
  • Marczyk, Michal; Gunasekharan, Vignesh; Casadevall Aguilar, David; Qing, Tao; Foldi, Julia; Sehgal, Raghav; Shan, Naing Lin; Blenman, Kim R.M.; O'Meara, Tess A.; Umlauf, Sheila; Surovtseva, Yulia V.; Muthusamy, Viswanathan; Rinehart, Jesse; Perry, Rachel J.; Kibbey, Richard; Hatzis, Christos; Pusztai, Lajos (American Association for Cancer Research (AACR), 2022)
    Metabolic reprogramming is a hallmark of malignant transformation, and loss of isozyme diversity (LID) contributes to this process. Isozymes are distinct proteins that catalyze the same enzymatic reaction but can have ...
  • Casadevall Aguilar, David; Vidal Barrull, Joana; Gallardo Hernández, Fernando; Zuccarino, Flavio; Arumí, Montserrat; Dalmases Massegú, Alba, 1982-; Bellosillo Paricio, Beatriz; Montagut Viladot, Clara (BioMed Central, 2016)
    BACKGROUND: Approximately 50 % of malignant melanomas harbor activating point mutations in the BRAF gene. Typically, these mutations result in the substitution of the amino acid valine at codon 600 of the gene, and 90-95 ...
  • Leis Machín, Angela 1974-; Casadevall Aguilar, David; Albanell Mestres, Joan; Posso, Margarita; Macià Guilà, Francesc Assís; Castells, Xavier; Ramírez Anguita, Juan Manuel; Martínez Roldán, Jordi; Furlong, Laura I., 1971-; Sanz, Ferran; Ronzano, Francesco; Mayer, Miguel Ángel, 1960- (JMIR Publications, 2022)
    Background: A cancer diagnosis is a source of psychological and emotional stress, which are often maintained for sustained periods of time that may lead to depressive disorders. Depression is one of the most common ...
  • O’Meara, Tess; Safonov, Anton; Casadevall Aguilar, David; Qing, Tao; Silber, Andrea; Killelea, Brigid; Hatzis, Christos; Pusztai, Lajos (Springer, 2019)
    PURPOSE: African-American (AA) patients with triple-negative breast cancer (TNBC) are less likely to achieve pathologic complete response from neoadjuvant chemotherapy and have poorer prognosis than Caucasian patients with ...
  • Arriola Aperribay, Edurne; Taus García, Álvaro; Casadevall Aguilar, David (Baishideng Publishing Group, 2015)
    Non-small cell lung cancer (NSCLC) is the most common type of lung cancer with a world-wide annual incidence of around 1.3 million. The majority of patients are diagnosed with advanced disease and survival remains poor. ...
  • Pérez-Núñez, Iván; Rozalén, Catalina; Palomeque, José Ángel; Sangrador, Irene; Dalmau, Mariona; Comerma Blesa, Laura, 1983-; Hernández Prat, Anna, 1984-; Casadevall Aguilar, David; Menendez Romero, Silvia; Liu, Dan; Berenguer De Felipe, Jordi; Peña Arranz, Raúl, 1976-; Montañés, José Carlos; Albà Soler, Mar; Bonnin, Sarah; Ponomarenko, Julia; Servitja Tormo, Sonia; Arribas, Joaquín; Albanell Mestres, Joan; Celià-Terrassa, Toni (Nature Research, 2022)
    Ligand-dependent corepressor (LCOR) mediates normal and malignant breast stem cell differentiation. Cancer stem cells (CSCs) generate phenotypic heterogeneity and drive therapy resistance, yet their role in immunotherapy ...
  • Casadevall Aguilar, David; Gimeno Beltran, Javier; Clavé Safont, Sergi; Taus García, Álvaro; Pijuan Andujar, Lara; Arumí de Dios, Miriam; Lorenzo Perez, Marta; Menendez Romero, Silvia; Cañadas Castillo, Israel, 1984-; Albanell Mestres, Joan; Serrano Figueras, Sergi; Espinet Solà, Blanca; Salido Galeote, Marta; Arriola Aperribay, Edurne (Impact Journals, 2015)
    OBJECTIVE: We aimed to assess MET intratumoral heterogeneity and its potential impact on biomarker-based patient selection as well as potential surrogate biomarkers of MET activation. METHODS: Our study included 120 patients ...
  • Casadevall Aguilar, David; Hernández Prat, Anna, 1984-; García-Alonso, Sara; Arpí Llucià, Oriol; Menéndez, Silvia; Qin, Mengjuan; Guardia Valenzuela, Cristina, 1990-; Morancho Armisen, Beatriz; Sánchez-Martín, Francisco Javier; Zazo, Sandra; Gavilán, Elena; Sabbaghi Mehrjardi, Mohammad Ali; Eroles, Pilar; Cejalvo, Juan M.; Lluch, Ana; Rojo, Federico; Pandiella, Atanasio; Rovira, Ana; Albanell Mestres, Joan (American Association for Cancer Research (AACR), 2022)
    In patients with trastuzumab-resistant HER2-positive breast cancer, the combination of everolimus (mTORC1 inhibitor) with trastuzumab failed to show a clinically significant benefit. However, the combination of mTOR ...
  • Esteve Palau, Erika; Gonzalez-Cuevas, Araceli; Guerrero, M. Eugenia; Garcia-Terol, Clara; Alvarez, M. Carmen; García, Geneva; Moreno, Encarna; Medina, Francesc-Xavier; Casadevall Aguilar, David; Diaz-Brito, V. (Oxford University Press, 2022)
    Background: several observational studies demonstrated the passage of postvaccine antibodies through breast milk in women vaccinated against coronavirus disease 2019 (COVID-19), mostly with messenger RNA (mRNA)-based ...
  • Esteve Palau, Erika; Gonzalez-Cuevas, Araceli; Guerrero, M. Eugenia; Garcia-Terol, Clara; Alvarez, M. Carmen; Casadevall Aguilar, David; Diaz-Brito, V. (American Medical Association, 2021)
    This cohort study assesses the concentration of SARS-CoV-2 antibodies in the breast milk of women who received vaccines for COVID-19 and their correlation with serum antibody levels.
  • Casadevall Aguilar, David; Kilian, Anaïs Yacine; Bellmunt Molins, Joaquim, 1959- (Elsevier, 2017)
    BACKGROUND: Despite adequate treatment and follow-up, around one fifth of patients with localized bladder cancer will present with disease progression. Adequate prognostic biomarkers are lacking to define patients who are ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking